Valuation: Kintor Pharmaceutical Limited

Market Cap 63Cr 74Cr 9.47Cr 8.42Cr 7.8Cr 7.1Cr 13Cr 898.77Cr 14Cr 94Cr 37Cr 469.01Cr 36Cr 35Cr 1.5TCr P/E 2024
-2.53x
P/E 2025 -3.96x
Enterprise Value 69Cr 81Cr 10Cr 9.13Cr 8.47Cr 7.7Cr 15Cr 975.16Cr 15Cr 101.76Cr 40Cr 508.88Cr 39Cr 38Cr 1.62TCr EV / Sales 2024
7,57,94,130x
EV / Sales 2025 2,82,45,180x
Free-Float
88.01%
Yield 2024 *
-
Yield 2025 -
1 day-3.53%
1 week-7.95%
Current month-14.49%
1 month-19.95%
3 months-18.65%
6 months-44.87%
Current year-23.21%
1 week 1.46
Extreme 1.465
1.68
1 month 1.46
Extreme 1.465
2.09
Current year 1.46
Extreme 1.465
4.7
1 year 1.46
Extreme 1.465
4.7
3 years 0.79
Extreme 0.79
4.7
5 years 0.79
Extreme 0.79
64
10 years 0.79
Extreme 0.79
89
Manager TitleAgeSince
Chief Executive Officer 64 24/03/2009
Director of Finance/CFO 48 21/09/2026
Chief Tech/Sci/R&D Officer 49 01/09/2020
Director TitleAgeSince
Director/Board Member 62 12/08/2019
Director/Board Member 61 12/08/2019
Chairman 64 24/03/2009
Date Insider Type Main position Quantity % Market Cap. Importance
17/07/26 Other

Chief Executive Officer

1,45,000 0.0291%
21/05/26 Other

Chief Executive Officer

38,000 0.0076%
18/05/26 Other

Chief Executive Officer

1,70,000 0.0341%
Change 5-day change 1-year change 3-year change Capi.($)
-3.53%-7.95%-30.00%-45.67% 9.47Cr
-6.60%-8.56%+42.79%+64.16% 6.5TCr
-4.09%-0.11%+2.31%+54.81% 5.12TCr
+0.03%+5.56%+10.18%+41.75% 5.12TCr
-1.53%+2.70%+29.72%+34.13% 4.39TCr
-1.34%+4.12%+16.05%+112.18% 4.2TCr
-5.97%-6.22%+258.21%+421.57% 3.81TCr
+6.53%+8.02%+15.74%+53.94% 3.32TCr
-0.90%-10.49%+31.48%-1.63% 2.52TCr
-2.76%-9.54%-16.53%-9.55% 2.2TCr
Average -2.02%-2.30%+35.99%+72.57% 3.72TCr
Weighted average by Cap. -2.30%-1.21%+43.54%+88.54%

Financials

2024 2025
Net sales 5 5.86 0.75 0.66 0.62 0.56 1.06 70.92 1.07 7.4 2.9 37.01 2.8 2.74 117.98 32.68 38.33 4.88 4.34 4.02 3.66 6.91 463.56 7.02 48.37 18.97 241.9 18.33 17.94 771.15
Net income -16Cr -18Cr -2.32Cr -2.06Cr -1.91Cr -1.74Cr -3.28Cr -220.26Cr -3.34Cr -23Cr -9.01Cr -114.94Cr -8.71Cr -8.52Cr -366.42Cr -20Cr -23Cr -2.99Cr -2.66Cr -2.46Cr -2.24Cr -4.23Cr -283.83Cr -4.3Cr -30Cr -12Cr -148.11Cr -11Cr -11Cr -472.16Cr
Net Debt -1.57Cr -1.84Cr -23.43L -20.83L -19.31L -17.57L -33.15L -22Cr -33.68L -2.32Cr -90.99L -12Cr -87.95L -86.07L -37Cr 5.39Cr 6.32Cr 80.5L 71.55L 66.32L 60.34L 1.14Cr 76Cr 1.16Cr 7.97Cr 3.13Cr 40Cr 3.02Cr 2.96Cr 127.09Cr
Projected Income Statement - Annual - Kintor Pharmaceutical Limited
Logo Kintor Pharmaceutical Limited
Kintor Pharmaceutical Ltd is an investment holding company primarily engaged in the research and development of innovative medicine products. The Company's products are dedicated to addressing disease areas that have not met clinical needs, and its pipeline mainly covers indications of dermatology (such as androgenetic alopecia, acne vulgaris) and indications of tumors. The Company has two core drugs in the dermatology field, KX-826 and GT20029. The Company's other disease areas include metastatic castration-resistant prostate cancer (mCRPC), liver cancer, idiopathic pulmonary fibrosis, malignant blood diseases and various solid tumors.
Employees
122
Date Price Change Volume
16/26/16 HK$1.505 -3.53% 7,72,500
15/26/15 HK$1.560 -1.58% 6,17,500
14/26/14 HK$1.585 -0.94% 7,22,500
13/26/13 HK$1.600 -4.76% 7,28,500
12/26/12 HK$1.680 +2.75% 8,66,000

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Kintor Pharmaceutical Limited
  1. Stock Market
  2. Stocks
  3. 9939 Stock